Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study
Nutrients · 14.02.2025 · 17 (4) · 691
DOI: 10.3390/nu17040691 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 14.02.2025. Verfasst von Su-Jin Jung und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Center for Functional Foods, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea. Hauptthemen laut MEDLINE: Probiotics, Cognitive Dysfunction, Lacticaseibacillus rhamnosus, Cognition. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, Ministry of Science and ICT, Republic of Korea, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries funded by the Ministry of Agriculture, Food, and Rural….
Abstract (Originalsprache)
Background
Probiotics have been shown to enhance cognitive function in individuals with mild cognitive impairment (MCI), but their efficacy varies, depending on the strain and dosage.
Objectives
Clinical investigations are crucial to confirm their safety, efficacy, and mechanism of action. This study was designed to assess the effective dosage, safety, and efficacy of MH-Pro, a test product containing Lacticaseibacillus rhamnosus CBT-LR5 (LR5) and skim milk (non-fat dry milk), in improving cognitive function and related physiological changes in older adults suspected of MCI over 12 weeks.
Methods
In total, 20 participants (mean age: 68.9 years) were randomly assigned in a 1:1 ratio to either a low-dose group (1 × 1010 CFU LR5 with 1622 mg) or a high-dose group (1 × 1010 CFU LR5 with 4055 mg skim milk) in a double-blind, parallel-group clinical trial.
Results
After 12 weeks, the low-dose group showed significant improvements in the MOCA-K subdomains, specifically in naming (p = 0.01) and delayed recall (p = 0.003). Additionally, levels of amyloid-β1 40/42 in the blood significantly decreased (p = 0.03) following supplementation in the low-dose group. The high-dose group exhibited significant improvement in orientation (p = 0.05). Moreover, overall cognitive enhancement was observed in the low-dose group (p = 0.003), while the high-dose group showed a trend toward improvement (p = 0.06). Fecal analysis revealed significant changes in bacterial composition, with an increase in Lacticaseibacillus after 12 weeks of MH-Pro consumption. Together, these findings provide foundational evidence suggesting that MH-Pro supplementation may serve as a potential intervention for enhancing cognitive function through gut–brain axis pathways in the elderly population. However, given the small sample size and the predominance of female participants, the impact of the outcome may be limited. Further large-scale studies are necessary to validate these preliminary results.
Conclusions
This study provides foundational evidence to recognize the use of LR5 and skim milk to prepare a probiotic supplement that enhances cognitive function in the aging population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Trial Center for Functional Foods, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
- Clinical Trial Center for K-FOOD Microbiome, Biomedical Research Institute, Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea.
- R&D Center, Cell Biotech Co., Ltd., Gimpo-si 10003, Republic of Korea.
- Department of Psychiatry, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea.
- Department of Gastroenterology and Hepatology, Jeonbuk National University Hospital, Jeonju 54896, Republic of Korea.
- Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju 54896, Republic of Korea.
ORCID-Profile: Su-Jin Jung, Kyohee Cho, Eun-Soo Jung, Song-In Kim, Sanghyun Lim
Förderung
- Ministry of Science and ICT
- Ministry of Science and ICT, Republic of Korea
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries funded by the Ministry of Agriculture, Food, and Rural…
Zitieren
APA
Jung, S. J., Cho, K., Jung, E. S., Son, D., Byun, J. S., Kim, S. I., Chae, S. W., Yang, J. C., Lee, S. O., & Lim, S. (2025). Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study. Nutrients, 17(4), 691. https://doi.org/10.3390/nu17040691
Vancouver
Jung SJ, Cho K, Jung ES, Son D, Byun JS, Kim SI, et al. Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study. Nutrients. 2025;17(4):691. doi:10.3390/nu17040691
BibTeX
@article{Jung2025,
author = {Jung, Su-Jin and Cho, Kyohee and Jung, Eun-Soo and Son, Dooheon and Byun, Jong-Seon and Kim, Song-In and Chae, Soo-Wan and Yang, Jong-Chul and Lee, Seung-Ok and Lim, Sanghyun},
title = {Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {4},
pages = {691},
doi = {10.3390/nu17040691}
}
EUVIMED